Clinical
ViRexx has several products in various stages of the clinical trial process. OvaRex® is currently in a Phase III clinical trial for the treatment of ovarian cancer. BrevaRex® has completed Phase I clinical testing in breast cancer and multiple myeloma. Occlusin™ Injection is currently in Phase I testing for hepatocellular carcinoma.